Profil
Melanie Rolli is currently an Independent Non-Executive Director at Santhera Pharmaceuticals Holding AG since 2025.
Former roles include Group Chief Executive Officer at Helsinn Healthcare SA from 2023 to 2026, Chief Executive Officer at Aelix Therapeutics SL, Independent Director at ERYTech Pharma SA from 2020 to 2023, and Chief Operating Officer at PIQUR Therapeutics AG from 2018 to 2020.
Education includes a doctorate from Ruprecht-Karls-Universität Heidelberg conferred in 1999.
Aktive Positionen von Melanie Rolli
| Unternehmen | Position | Beginn |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Direktor/Vorstandsmitglied | 20.05.2025 |
Ehemalige bekannte Positionen von Melanie Rolli
| Unternehmen | Position | Ende |
|---|---|---|
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 12.01.2026 |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Direktor/Vorstandsmitglied | 23.06.2023 |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Develops novel vaccines to cure HIV infection | Vorstandsvorsitzender | - |
PIQUR Therapeutics AG
PIQUR Therapeutics AG Pharmaceuticals: MajorHealth Technology Engages in discovery and development of anti-cancer drugs | Vorstandsvorsitzender | - |
Ausbildung von Melanie Rolli
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Health Technology |
PIQUR Therapeutics AG
PIQUR Therapeutics AG Pharmaceuticals: MajorHealth Technology Engages in discovery and development of anti-cancer drugs | Health Technology |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Develops novel vaccines to cure HIV infection | Health Technology |
















